Bellevue Life Sciences Ac...
(BLAC)
undefined
undefined%
At close: undefined
11.32
0.00%
After-hours Dec 12, 2024, 02:38 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | 36.56 | -646.09 | -6052.98 | -836.65 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | 0.45 | -609.57 | -9444.93 | 16769.57 |
P/FCF Ratio | -18.03 | -5398.79 | -43434.38 | -836.65 |
P/OCF Ratio | -18.03 | -5398.79 | -43434.38 | -836.65 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | 0.00 | -8.00 | -47.17 | 63.13 |
Quick Ratio | 0.00 | 0.02 | 0.00 | 0.05 |
Current Ratio | 0.00 | 0.02 | 0.00 | 0.05 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
Return on Equity (ROE) | 1.24% | 94.35% | 156.04% | -2004.38% |
Return on Assets (ROA) | 1.10% | -2.89% | -0.47% | -7.38% |
Return on Capital (ROIC) | -5.29% | 94.35% | 156.04% | -2004.21% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |